Early-stage hepatocellular carcinoma: The high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment

European Radiology, Supplement

Volumn 17, Issue SUPPL. 6, 2007, Pages

  Nicolau, Carlos ^a   Vilana, Ramon ^a   Bianchi, Luis ^a   Brú, Concepcio ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma; Percutaneous ablation; Treatment response

Indexed keywords

ALCOHOL; CONTRAST MEDIUM; SON VUE; SONOVUE; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY CANCER; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MICROVASCULATURE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REAL TIME ECHOGRAPHY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

EID: 40349113041     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-007-0232-7     Document Type: Article

References (35)

1. 1. J. Bruix M. Sherman J.M. Llovet 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 11592607 10.1016/S0168-8278(01)00130-1 1:STN:280:DC%2BD3MrksFCmtg%3D%3D Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
2. 2. J. Bruix M. Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 16250051 10.1002/hep.20933 Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
3. 3. R.A. Lencioni H.P. Allgaier D. Cioni 2003 Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 1 235 240 12759473 10.1148/radiol.2281020718 Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228(1):235–240
4. 4. R. Lencioni D. Cioni L. Crocetti 2005 Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 3 961 967 15665226 10.1148/radiol.2343040350 Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3):961–967
5. 5. T. Livraghi A. Giorgio G. Marin 1995 Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection Radiology 197 101 108 7568806 1:STN:280:DyaK28%2FitlWgsw%3D%3D Livraghi T, Giorgio A, Marin G et al (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108
6. 6. T. Livraghi L. Solbiati M.F. Meloni 2003 Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study Radiology 226 2 441 451 12563138 10.1148/radiol.2262012198 Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226(2):441–451
7. 7. T. Baere de O. Risse V. Kuoch 2003 Adverse events during radiofrequency treatment of 582 hepatic tumors AJR Am J Roentgenol 181 3 695 700 12933462 de Baere T, Risse O, Kuoch V et al (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181(3):695–700
8. 8. O. Seror G. N’Kontchou M. Tin Tin Htar 2006 Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost Gastroenterol Clin Biol 30 11 1265 1273 17185968 10.1016/S0399-8320(06)73534-5 Seror O, N’Kontchou G, Tin Tin Htar M et al (2006) Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost. Gastroenterol Clin Biol 30(11):1265–1273
9. 9. S.M. Lin C.J. Lin C.C. Lin 2004 Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm Gastroenterology 127 6 1714 1723 15578509 10.1053/j.gastro.2004.09.003 Lin SM, Lin CJ, Lin CC et al (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127(6):1714–1723
10. 10. S. Shiina T. Teratani S. Obi 2005 A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 1 122 130 16012942 10.1053/j.gastro.2005.04.009 Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129(1):122–130
11. 11. M. Sala J.M. Llovet R. Vilana 2004 Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology 40 1352 1360 15565564 10.1002/hep.20465 Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360
12. 12. H.K. Lim D. Choi W.J. Lee 2001 Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT Radiology 221 2 447 454 11687689 10.1148/radiol.2212010446 1:STN:280:DC%2BD3MnjvFCntg%3D%3D Lim HK, Choi D, Lee WJ et al (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221(2):447–454
13. 13. M. Burrel J.M. Llovet C. Ayuso 2003 MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation Hepatology 38 4 1034 1042 14512891 Burrel M, Llovet JM, Ayuso C et al (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38(4):1034–1042
14. 14. S.K. Kim H.K. Lim Y.H. Kim 2003 Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings Radiographics 23 1 107 121 12533646 10.1148/rg.231025055 Kim SK, Lim HK, Kim YH et al (2003) Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 23(1):107–121
15. 15. S.N. Goldberg G.S. Gazelle C.C. Compton 2000 Treatment of intrahepatic malignancy with radiofrequency ablation: radiologicpathologic correlation Cancer 88 11 2452 2463 10861420 10.1002/1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3 1:STN:280:DC%2BD3cvisFyksg%3D%3D Goldberg SN, Gazelle GS, Compton CC et al (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologicpathologic correlation. Cancer 88(11):2452–2463
16. 16. P. Marckmann L. Skov K. Rossen A. Dupont 2006 Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 9 2359 2362 16885403 10.1681/ASN.2006060601 Marckmann P, Skov L, Rossen K, Dupont A et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17(9):2359–2362
17. 17. D.R. Broome M.S. Girguis P.W. Baron 2007 Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned AJR Am J Roentgenol 188 2 586 592 17242272 10.2214/AJR.06.1094 Broome DR, Girguis MS, Baron PW et al (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188(2):586–592
18. 18 R. Vilana J.M. Llovet L. Bianchi 2003 Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation J Clin Ultrasound 31 3 119 128 12594796 10.1002/jcu.10151 Vilana R, Llovet JM, Bianchi L et al (2003) Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound 31(3):119–128
19. 19. D. Choi H.K. Lim S.H. Kim 2000 Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results Radiology 217 2 558 563 11058660 1:STN:280:DC%2BD3crhtFCiuw%3D%3D Choi D, Lim HK, Kim SH et al (2000) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 217(2):558–563
20. 20. C. Nicolau V. Catala R. Vilana 2004 Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation Eur Radiol 14 1092 1099 15007620 10.1007/s00330-004-2298-0 Nicolau C, Catala V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099
21. 21. A. Giorgio G. Ferraioli L. Tarantino 2004 Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance AJR Am J Roentgenol 183 1319 1326 15505297 Giorgio A, Ferraioli G, Tarantino L et al (2004) Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 183:1319–1326
22. 22. S. Gaiani N. Celli F. Piscaglia 2004 Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography J Hepatol 41 421 426 15336445 10.1016/j.jhep.2004.04.022 Gaiani S, Celli N, Piscaglia F et al (2004) Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41:421–426
23. 23 V. Catala C. Nicolau R. Vilana 2007 Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography Eur Radiol 17 4 1066 1073 17072617 10.1007/s00330-006-0444-6 1:STN:280:DC%2BD2s7ktVCmug%3D%3D Catala V, Nicolau C, Vilana R et al (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17(4):1066–1073
24. 24. L. Bolondi S. Gaiani N. Celli 2005 Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma Hepatology 42 27 34 15954118 10.1002/hep.20728 Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34
25. 25. P.N. Burns S.R. Wilson 2007 Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images Radiology 242 1 162 174 17090710 10.1148/radiol.2421051006 Burns PN, Wilson SR (2007) Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images. Radiology 242(1):162–174
26. 26. R. Vilana L. Bianchi M. Varela 2006 Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16 2454 2462 16710666 10.1007/s00330-006-0264-8 1:STN:280:DC%2BD28njsVemtw%3D%3D Vilana R, Bianchi L, Varela M et al (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16:2454–2462
27. 27. M.J. Dill-Macky M. Asch P. Burns S. Wilson 2006 Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography AJR Am J Roentgenol 186 287 295 10.2214/AJR.04.1916 Dill-Macky MJ, Asch M, Burns P, Wilson S (2006) Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 186:287–295
28. 28. Y.L. Wen M. Kudo R.Q. Zheng 2003 Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography AJR Am J Roentgenol 181 1 57 63 12818830 Wen YL, Kudo M, Zheng RQ et al (2003) Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 181(1):57–63
29. 29. D. Choi H.K. Lim W.J. Lee 2003 Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent J Ultrasound Med 22 11 1163 1172 14620886 Choi D, Lim HK, Lee WJ et al (2003) Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 22(11):1163–1172
30. 30. C.K. Kim D. Choi H.K. Lim 2005 Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging Eur J Radiol 56 1 66 73 15913940 10.1016/j.ejrad.2005.03.023 Kim CK, Choi D, Lim HK et al (2005) Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 56(1):66–73
31. 31. Y. Imai N. Okamoto N. Tateiwa 2006 Assessment of treatment efficacy in radiofrequency ablation for hepatocellular carcinoma: comparison between multiplanar reconstruction by multi-detector row CT and contrast-enhanced ultrasonography by Truagent detection mode Hepatol Res 35 1 69 75 16531112 10.1016/j.hepres.2006.02.002 Imai Y, Okamoto N, Tateiwa N et al (2006) Assessment of treatment efficacy in radiofrequency ablation for hepatocellular carcinoma: comparison between multiplanar reconstruction by multi-detector row CT and contrast-enhanced ultrasonography by Truagent detection mode. Hepatol Res 35(1):69–75
32. 32. Y. Kisaka M. Hirooka T. Kumagi 2006 Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation Liver Int 26 10 1241 1247 17105590 10.1111/j.1478-3231.2006.01367.x Kisaka Y, Hirooka M, Kumagi T et al (2006) Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 26(10):1241–1247
33. 33. T. Albrecht M. Blomley L. Bolondi 2004 Guidelines for the use of contrast agents in ultrasound. January 2004 Ultraschall Med 25 4 249 256 15300497 10.1055/s-2004-813245 1:STN:280:DC%2BD2cvltFajtg%3D%3D Albrecht T, Blomley M, Bolondi L et al (2004) Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 25(4):249–256
34. 34. L. Solbiati T. Ierace M. Tonolini 2004 Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound Eur J Radiol 51 [Suppl] S19 S23 15311434 10.1016/j.ejrad.2004.03.035 Solbiati L, Ierace T, Tonolini M et al (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51[Suppl]:S19–S23
35. 35. L. Solbiati M. Tonolini T. Ierace 2006 Guidance of percutaneous tumor ablation procedures R. Lencioni Enhancing the role of ultrasound with contrast agents Springer-Verlag Heidelberg 69 10.1007/88-470-0476-4_5 Solbiati L, Tonolini M, Ierace T (2006) Guidance of percutaneous tumor ablation procedures. In: Lencioni R (ed) Enhancing the role of ultrasound with contrast agents. Springer-Verlag, Heidelberg, p 69